- Home
- NUS vs ZTR Comparison
NUS vs ZTR Comparison
Compare NUS & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUS
- ZTR
- Stock Information
- Founded
- NUS 1984
- ZTR 1988
- Country
- NUS United States
- ZTR Australia
- Employees
- NUS N/A
- ZTR N/A
- Industry
- NUS Other Pharmaceuticals
- ZTR Investment Managers
- Sector
- NUS Health Care
- ZTR Finance
- Exchange
- NUS Nasdaq
- ZTR Nasdaq
- Market Cap
- NUS 353.9M
- ZTR 368.5M
- IPO Year
- NUS 1996
- ZTR N/A
- Fundamental
- Price
- NUS $6.88
- ZTR $6.02
- Analyst Decision
- NUS Hold
- ZTR
- Analyst Count
- NUS 2
- ZTR 0
- Target Price
- NUS $6.88
- ZTR N/A
- AVG Volume (30 Days)
- NUS 743.8K
- ZTR 219.4K
- Earning Date
- NUS 02-13-2025
- ZTR 01-01-0001
- Dividend Yield
- NUS 3.41%
- ZTR 12.09%
- EPS Growth
- NUS N/A
- ZTR N/A
- EPS
- NUS N/A
- ZTR N/A
- Revenue
- NUS $1,775,172,000.00
- ZTR N/A
- Revenue This Year
- NUS N/A
- ZTR N/A
- Revenue Next Year
- NUS N/A
- ZTR N/A
- P/E Ratio
- NUS N/A
- ZTR N/A
- Revenue Growth
- NUS N/A
- ZTR N/A
- 52 Week Low
- NUS $5.95
- ZTR $4.50
- 52 Week High
- NUS $18.97
- ZTR $6.60
- Technical
- Relative Strength Index (RSI)
- NUS 48.90
- ZTR 54.50
- Support Level
- NUS $6.71
- ZTR $5.92
- Resistance Level
- NUS $7.21
- ZTR $5.99
- Average True Range (ATR)
- NUS 0.34
- ZTR 0.08
- MACD
- NUS 0.01
- ZTR 0.02
- Stochastic Oscillator
- NUS 60.50
- ZTR 79.09
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective is capital appreciation, with current income as a secondary objective through a balance of equity and fixed income investments. It invests in operators of infrastructure in the communications, utility, energy, and transportation industries.